Evidence map›Paper›PMID 30207066›Full record

ArticleJournal of thrombosis and haemostasis : JTH2018

Protein disulfide isomerase regulation by nitric oxide maintains vascular quiescence and controls thrombus formation.

R H Bekendam, D Iyu, F Passam, J D Stopa, K De Ceunynck, O Muse, P K Bendapudi, C L Garnier, S Gopal, L Crescence and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Platelets welcome a new protein disulfide isomerase family member.Journal of thrombosis and haemostasis : JTH · 2025
    Article
  9. Article
  10. Article
  11. Cysteine and methionine oxidation in thrombotic disorders.Current opinion in chemical biology · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 4 countries.

R H BekendamAix Marseille Université, INSERM, UMR-S1076, Vascular Research Center Marseille, Marseille, France.
D IyuDepartment of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
F PassamSt George Clinical School, University of New South Wales, Kogarah, New South Wales, Australia.
J D StopaDepartment of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
K De CeunynckDepartment of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
O MuseDepartment of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
P K BendapudiDepartment of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
C L GarnierDepartment of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
S GopalDepartment of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
L CrescenceAix Marseille Université, INSERM, UMR-S1076, Vascular Research Center Marseille, Marseille, France.
J ChiuThe Centenary Institute, NHMRC Clinical Trials Centre, Sydney Medical School, University of Sydney New South Wales, Sydney, New South Wales, Australia.
B FurieDepartment of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
L Panicot-DuboisAix Marseille Université, INSERM, UMR-S1076, Vascular Research Center Marseille, Marseille, France.
P J HoggThe Centenary Institute, NHMRC Clinical Trials Centre, Sydney Medical School, University of Sydney New South Wales, Sydney, New South Wales, Australia.
C DuboisAix Marseille Université, INSERM, UMR-S1076, Vascular Research Center Marseille, Marseille, France.
R FlaumenhaftDepartment of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Beth Israel Deaconess Medical Center · USInserm · FRAix-Marseille Université · FRCentenary Institute · AUInstituto Murciano de Investigación Biosanitaria · ESNational Health and Medical Research Council · AUUNSW Sydney · AU

Funding

PROGRAM IN BLOOD COAGULATION AND VASCULAR BIOLOGYT32HL007917 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Robert C Flaumenhaft · 1999 to 2026
$11.1M
Translational Research Skills DevelopmentU54HL112302 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FURIE, BRUCE · 2012 to 2016
$11.1M
Thiol Isomerases in Hemostasis and ThrombosisR35HL135775 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FLAUMENHAFT, ROBERT C · 2017 to 2023
$5.5M
Targeting the Endothelium in SepsisR01HL125275 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FLAUMENHAFT, ROBERT C, PARIKH, SAMIR M · 2014 to 2018
$4.2M
Vascular Thiol Isomerases in ThrombosisR01HL136394 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ITALIANO, JOSEPH E, ZWICKER, JEFFREY · 2017 to 2020
$3.3M
The Role of Coagulation Factor XII in Hemostasis and ThrombosisK08HL136840 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BENDAPUDI, PAVAN · 2017 to 2021
$817k
NHLBI NIH HHS K08 HL136840NHLBI NIH HHS R01 HL125275NHLBI NIH HHS R01 HL136394NHLBI NIH HHS R35 HL135775NHLBI NIH HHS T32 HL007917NHLBI NIH HHS U54 HL112302
6 · The paper itself

Abstract

Essentials Nitric oxide synthesis controls protein disulfide isomerase (PDI) function. Nitric oxide (NO) modulation of PDI controls endothelial thrombogenicity. S-nitrosylated PDI inhibits platelet function and thrombosis. Nitric oxide maintains vascular quiescence in part through inhibition of PDI. SUMMARY: Background Protein disulfide isomerase (PDI) plays an essential role in thrombus formation, and PDI inhibition is being evaluated clinically as a novel anticoagulant strategy. However, little is known about the regulation of PDI in the vasculature. Thiols within the catalytic motif of PDI are essential for its role in thrombosis. These same thiols bind nitric oxide (NO), which is a potent regulator of vessel function. To determine whether regulation of PDI represents a mechanism by which NO controls vascular quiescence, we evaluated the effect of NO on PDI function in endothelial cells and platelets, and thrombus formation in vivo. Aim To assess the effect of S-nitrosylation on the regulation of PDI and other thiol isomerases in the vasculature. Methods and results The role of endogenous NO in PDI activity was evaluated by incubating endothelium with an NO scavenger, which resulted in exposure of free thiols, increased thiol isomerase activity, and enhanced thrombin generation on the cell membrane. Conversely, exposure of endothelium to NO

Indexed as

Abdominal MusclesAnimalsBlood PlateletsCell MembraneEndothelial CellsFactor XaHumansHuman Umbilical Vein Endothelial CellsMiceMice, Inbred C57BLNitric OxidePlatelet ActivationPlatelet AggregationProtein Disulfide-IsomerasesP-SelectinRecombinant ProteinsFactor XaNitric OxideProtein Disulfide-IsomerasesP-SelectinRecombinant ProteinsSulfhydryl CompoundsThrombinnitric oxideplateletsprotein disulfide isomeraseS-nitrosylationthrombosis

Identifiers

PMID30207066
PMCPMC6374154
OpenAlexW2892368055

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.